跳至主要内容
临床试验/NCT01790789
NCT01790789已完成不适用

Stress Reduction During Primary Adjuvant Chemotherapy for Ovarian Cancer

University of Wisconsin, Madison2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
41
试验地点
2
主要终点
Fatigue

研究概览

简要总结

The purpose of this study is to investigate the effects of a stress reduction program on the quality of life of ovarian cancer patients during primary adjuvant chemotherapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subjects must have an initial diagnosis of ovarian, fallopian tube or primary peritoneal cancer who completed primary ovarian cancer surgery or 3 cycles of neoadjuvant chemotherapy with interval cytoreductive surgery (ICS).
  • Final pathology diagnosis of stage I-IV ovarian, fallopian tube or primary peritoneal cancer with plan to receive primary adjuvant chemotherapy or completion of chemotherapy after ICS.
  • Receive chemotherapy at the University of Wisconsin-Madison.
  • Subjects must be at least 18 years of age.
  • English-speaking
  • Subjects must be able to use audio media, and read and understand the study manual.
  • ECOG performance status 0-
  • Subjects must have a phone.

排除标准

  • Subjects participating in a meditation practice more than 1 hour per week prior to surgery and/or chemotherapy administration.
  • Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer.
  • Subjects with diagnosis of Chronic Fatigue Syndrome (CFS).
  • Subjects unable to use audio media due to auditory dysfunction.
  • Subjects unable to read written English.
  • Subjects who are prisoners or incarcerated.

结局指标

主要结局

Fatigue

时间窗: 18 weeks (completion of chemotherapy)

Fatigue will be measured using the NIH PROMIS Cancer Fatigue survey instrument

次要结局

  • Natural Killer Cell Activity(18 weeks (completion of chemotherapy))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验